株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

精密医療(プレシジョンメディシン)ソフトウェアの世界市場

Global Precision Medicine Software 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 888694
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
精密医療(プレシジョンメディシン)ソフトウェアの世界市場 Global Precision Medicine Software 2019-2025
出版日: 2019年06月28日 ページ情報: 英文
概要

当レポートでは、世界の精密医療(プレシジョンメディシン)ソフトウェア市場を調査し、市場の概要、用途・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 調査概要

  • 調査手法とツール
  • 市場の内訳:セグメント別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの考察と市場の現況
    • 主な調査結果
    • 提言
    • 総論
  • 規制

第3章 競合情勢

  • コンペティティブダッシュボード
  • 主要戦略の分析
  • 主要企業の分析
    • 概要
    • SWOT分析
    • 近年の動向

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 世界の精密医療ソフトウェア市場の分析:セグメント別

  • 世界の精密医療ソフトウェア市場:用途別
    • がん・腫瘍
    • ファーマコゲノミクス(PGx)
    • 稀少疾患
  • 世界の精密医療ソフトウェア市場:エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 病院・診療所
    • 研究機関・政府機関

第6章 世界の精密医療ソフトウェア市場の分析:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • 2bPrecise, LLC
  • Diaceutics Group
  • DNA Software Inc.
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Gene42 Inc.
  • Genospace, LLC
  • Golden Helix, Inc.
  • Human Longevity, Inc.
  • Intel Corp.
  • IBM Corp.
  • Itransition Holding Ltd.
  • Koninklijke Philips N.V.
  • Labcyte Inc.
  • LifeOmic Health, LLC
  • MolecularMatch Inc.
  • NantHealth, Inc.
  • Qiagen N.V.
  • PierianDx, Inc.
  • SOPHiA GENETICS S.A.
  • Sunquest Information Systems, Inc.
  • Syapse, Inc.
  • Tempus Labs
  • Translational Software Inc.
図表

List of Tables

  • 1. GLOBAL PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 2. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL PHARMACOGENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL RARE DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 6. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL HOSPITAL AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL RESEARCH CENTERS AND GOVERNMENT INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 10. NORTH AMERICAN PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 11. NORTH AMERICAN PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 13. EUROPEAN PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 14. EUROPEAN PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 15. EUROPEAN PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 16. ASIA-PACIFIC PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. ASIA-PACIFIC PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 19. REST OF THE WORLD PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 20. REST OF THE WORLD PRECISION MEDICINE SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL PRECISION MEDICINE SOFTWARE MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 2. GLOBAL PRECISION MEDICINE SOFTWARE MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 3. GLOBAL PRECISION MEDICINE SOFTWARE MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD PRECISION MEDICINE SOFTWARE MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019738

Global Precision Medicine Software Market Size, Share & Trends Analysis Report by Application (Oncology, Pharmacogenomics, and Rare diseases) and by End-User (Pharmaceutical and Biotechnology Companies, Hospital and Clinics, Research Centers and Government Institutes) and Forecast, 2019-2025

Precision medicine software is an essential data driven tools used by the healthcare providers and research institutes for the study of oncology, pharmacogenomics, and evaluation of the rare disease. Global precision medicine software market is growing due to various factors such as rising government initiatives for using precision medicine and entrance of new market players in the precision medicine software market. Moreover, the rising trends towards precision medicines in oncology and pharmacogenomics application would propel the market growth in the near future. However, concern related to the secure storage of a large amount of data may hamper market growth. The introduction of AI in precision medicine and rising cloud-based solutions further provides growth opportunities for the global precision medicine software market.

Geographically, the global precision medicine software market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America is projected to have a significant market share in the global precision medicine software market during the forecast period. The factors that are contributing to the growth of the market in the region includes well-developed healthcare infrastructure, rising number of cancer patients, and increasing R&D investment by the pharmaceutical and biotechnology companies for genomic research. Moreover, Asia-Pacific is estimated to exhibit considerable market growth in the global precision medicine software market during the forecast period. The growth is mainly due to the increasing collaborations between software and pharmaceutical companies to enhance the R&D activities. Moreover, the rising awareness for the use of precision medicine in cancer and other disease treatment is anticipated to propel the growth of the market in the region.

The global precision medicine software market is influenced by product development and technological advancements conducted by the market players. The key players of the global precision medicine software market include 2bPrecise, LLC, Gene42 Inc., Intel Corp., IBM Corp., Koninklijke Philips N.V., LifeOmic Health, LLC, PierianDx, Inc., Syapse, Inc., Tempus Labs, Translational Software Inc., NantHealth, Inc., and Genospace, LLC. These players are playing a significant role in the growth of the precision medicine software market by providing various innovative software solutions and adopting several strategies such as a merger and acquisition, partnerships and collaboration, technological development, and others. For instance, in January 2017, Genospace, LLC and Sarah Cannon announced the merger for the development of cancer care solution through precision medicine platform.

Research Methodology

The market study of the global precision medicine software market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalogue

The report is intended for precision medicine software providers, research institutes, biotechnology companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Precision Medicine Software Market Research and Analysis by Application
  • 2. Global Precision Medicine Software Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global precision medicine software market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global precision medicine software market.
  • Insights about market determinants which are stimulating the global precision medicine software market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. SWOT Analysis
    • 3.3.3. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Precision Medicine Software Market by Application
    • 5.1.1. Oncology
    • 5.1.2. Pharmacogenomics
    • 5.1.3. Rare diseases
  • 5.2. Global Precision Medicine Software Market by End-User
    • 5.2.1. Pharmaceutical and Biotechnology Companies
    • 5.2.2. Hospital and Clinics
    • 5.2.3. Research Centers and Government Institutes

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 2bPrecise, LLC
  • 7.2. Diaceutics Group
  • 7.3. DNA Software Inc.
  • 7.4. Fabric Genomics, Inc.
  • 7.5. Foundation Medicine, Inc.
  • 7.6. Gene42 Inc.
  • 7.7. Genospace, LLC
  • 7.8. Golden Helix, Inc.
  • 7.9. Human Longevity, Inc.
  • 7.10. Intel Corp.
  • 7.11. IBM Corp.
  • 7.12. Itransition Holding Ltd.
  • 7.13. Koninklijke Philips N.V.
  • 7.14. Labcyte Inc.
  • 7.15. LifeOmic Health, LLC
  • 7.16. MolecularMatch Inc.
  • 7.17. NantHealth, Inc.
  • 7.18. Qiagen N.V.
  • 7.19. PierianDx, Inc.
  • 7.20. SOPHiA GENETICS S.A.
  • 7.21. Sunquest Information Systems, Inc.
  • 7.22. Syapse, Inc.
  • 7.23. Tempus Labs
  • 7.24. Translational Software Inc.
Back to Top